Genetic Modulation of RNA Splicing with a CRISPR-Guided Cytidine Deaminase-Reference-Cited by-同舟云学术

Genetic Modulation of RNA Splicing with a CRISPR-Guided Cytidine Deaminase

Published:2018-10 Issue:2 Volume:72 Page:380-394.e7
ISSN:1097-2765
Container-title:Molecular Cell
language:en
Short-container-title:Molecular Cell

Author:

Yuan Juanjuan,Ma Yunqing,Huang Tao,Chen Yanhao,Peng Yuanzheng,Li Bing,Li Jia,Zhang Yuchen,Song Bing,Sun Xiaofang,Ding Qiurong,Song Yan,Chang Xing^ORCID

Funder

Ministry of Science and Technology, China

National Natural Science Foundation of China

Strategic Priority Research Program

Chinese Academy of Sciences

Shanghai Municipal Science and Technology Commission

The Department of Science and Technology of Guangdong Province

Publisher

Elsevier BV

Subject

Cell Biology,Molecular Biology

Reference47 articles.

1. Exonic sequences provide better targets for antisense oligonucleotides than splice site sequences in the modulation of Duchenne muscular dystrophy splicing;Aartsma-Rus;Oligonucleotides,2010

2. Detecting differential usage of exons from RNA-seq data;Anders;Genome Res.,2012

3. Dynamic integration of splicing within gene regulatory pathways;Braunschweig;Cell,2013

4. Widespread intron retention in mammals functionally tunes transcriptomes;Braunschweig;Genome Res.,2014

5. miR-31 modulates dystrophin expression: new implications for Duchenne muscular dystrophy therapy;Cacchiarelli;EMBO Rep.,2011

Cited by 120 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A comprehensive review on the current status of CRISPR based clinical trials for rare diseases;International Journal of Biological Macromolecules;2024-10

2. A CRISPR-dCas13 RNA-editing tool to study alternative splicing;Nucleic Acids Research;2024-08-20

3. Engineered IscB–ωRNA system with expanded target range for base editing;Nature Chemical Biology;2024-08-15

4. Adenine base editing-mediated exon skipping restores dystrophin in humanized Duchenne mouse model;Nature Communications;2024-07-15

5. In vivo CRISPR base editing for treatment of Huntington’s disease;2024-07-07